Segui
Didier Bazile
Didier Bazile
Head of CMC External Innovation
Email verificata su sanofi.com
Titolo
Citata da
Citata da
Anno
Stealth Me. PEG‐PLA nanoparticles avoid uptake by the mononuclear phagocytes system
D Bazile, C Prud'homme, MT Bassoullet, M Marlard, G Spenlehauer, ...
Journal of pharmaceutical sciences 84 (4), 493-498, 1995
7361995
Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators
M Vittaz, D Bazile, G Spenlehauer, T Verrecchia, M Veillard, F Puisieux, ...
Biomaterials 17 (16), 1575-1581, 1996
2491996
Body distribution of fully biodegradable [14C]-poly (lactic acid) nanoparticles coated with albumin after parenteral administration to rats
DV Bazile, C Ropert, P Huve, T Verrecchia, M Mariard, A Frydman, ...
Biomaterials 13 (15), 1093-1102, 1992
2441992
The design of nanoparticles obtained by solvent evaporation: a comprehensive study
S Desgouilles, C Vauthier, D Bazile, J Vacus, JL Grossiord, M Veillard, ...
Langmuir 19 (22), 9504-9510, 2003
2402003
Non-stealth (poly (lactic acid/albumin)) and stealth (poly (lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers
T Verrecchia, G Spenlehauer, DV Bazile, A Murry-Brelier, Y Archimbaud, ...
Journal of Controlled Release 36 (1-2), 49-61, 1995
2371995
Process for preparing nanoparticles
G Spenleuhauer, D Bazile, M Veillard, C Prud'Homme, JP Michalon
US Patent 5,766,635, 1998
1621998
Adsorption/desorption of human serum albumin at the surface of poly (lactic acid) nanoparticles prepared by a solvent evaporation process
T Verrecchia, P Huve, D Bazile, M Veillard, G Spenlehauer, P Couvreur
Journal of biomedical materials research 27 (8), 1019-1028, 1993
991993
Degradation of poly (D, L-lactic acid) nanoparticles coated with albumin in model digestive fluids (USP XXII)
FB Landry, DV Bazile, G Spenlehauer, M Veillard, J Kreuter
Biomaterials 17 (7), 715-723, 1996
871996
Comparison of the safety profiles of PLA50 and Me. PEG-PLA50 nanoparticles after single dose intravenous administration to rat
JP Plard, D Bazile
Colloids and surfaces B: Biointerfaces 16 (1-4), 173-183, 1999
781999
Drug delivery design for intravenous route with integrated physicochemistry, pharmacokinetics and pharmacodynamics: illustration with the case of taxane therapeutics
LH Reddy, D Bazile
Advanced Drug Delivery Reviews 71, 34-57, 2014
772014
Y-shaped mPEG-PLA cabazitaxel conjugates: well-controlled synthesis by organocatalytic approach and self-assembly into interface drug-loaded core–corona nanoparticles
F Bensaid, O Thillaye du Boullay, A Amgoune, C Pradel, ...
Biomacromolecules 14 (4), 1189-1198, 2013
632013
Oral delivery of diabetes peptides—Comparing standard formulations incorporating functional excipients and nanotechnologies in the translational context
HR Lakkireddy, M Urmann, M Besenius, U Werner, T Haack, P Brun, ...
Advanced Drug Delivery Reviews 106, 196-222, 2016
562016
Influence of lipid nanocapsules composition on their aptness to freeze-drying
C Dulieu, D Bazile
Pharmaceutical research 22 (2), 285-292, 2005
562005
Precise engineering of multifunctional PEGylated polyester nanoparticles for cancer cell targeting and imaging
N Mackiewicz, J Nicolas, N HandkÚ, M Noiray, J Mougin, C Daveu, ...
Chemistry of Materials 26 (5), 1834-1847, 2014
542014
α-DNA VIII: thermodynamic parameters of complexes formed between the oligo-alpha-deoxynucleotides: α-d (GGAAGG) and α-d (CCTTCC) and their complementary oligo-betaá…
J Paoletti, D Bazile, F Morvan, JL Imbach, C Paoletti
Nucleic acids research 17 (7), 2693-2704, 1989
521989
Influence of coating agents on the degradation of poly (d, l-lactic acid) nanoparticles in model digestive fluids (USP XXII)
FB Landry, DV Bazile, G Spenlehauer, M Veillard, J Kreuter
STP pharma sciences 6 (3), 195-202, 1996
481996
Encapsulation of oligonucleotides in stealth Me.PEG-PLA50 nanoparticles by complexation with structured oligopeptides
C Emile, D Bazile, F Herman, C Helene, M Veillard
Drug Delivery 3 (3), 187-195, 1996
461996
Physicochemical, pharmacokinetic and pharmacodynamic analyses of amphiphilic cyclodextrin-based nanoparticles designed to enhance intestinal delivery of insulin
E Presas, F McCartney, E Sultan, C Hunger, S Nellen, CV Alvarez, ...
Journal of controlled release 286, 402-414, 2018
412018
Release of the fluorescent marker Prodan« from poly (D, L-lactic acid) nanoparticles coated with albumin or polyvinyl alcohol in model digestive fluids (USP XXII)
FB Landry, DV Bazile, G Spenlehauer, M Veillard, J Kreuter
Journal of controlled release 44 (2-3), 227-236, 1997
381997
Bridging communities in the field of nanomedicine
B Halamoda-Kenzaoui, S Baconnier, T Bastogne, D Bazile, P Boisseau, ...
Regulatory Toxicology and Pharmacology 106, 187-196, 2019
342019
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20